| Attribute |
Value |
| 52 Week Change |
-0.13000482 |
| Address1 |
9,001 Spectrum Center Boulevard |
| All Time High |
301.34 |
| All Time Low |
0.609375 |
| Ask |
240.41 |
| Ask Size |
200 |
| Audit Risk |
1 |
| Average Analyst Rating |
2.4 - Buy |
| Average Daily Volume10 Day |
1,416,880 |
| Average Daily Volume3 Month |
1,520,866 |
| Average Volume |
1,520,866 |
| Average Volume10Days |
1,416,880 |
| Beta |
0.748 |
| Bid |
212.0 |
| Bid Size |
100 |
| Board Risk |
7 |
| Book Value |
45.656 |
| City |
San Diego |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
4 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
240.33 |
| Current Ratio |
3.1 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,786,665,600 |
| Day High |
241.025 |
| Day Low |
235.515 |
| Debt To Equity |
12.542 |
| Display Name |
ResMed |
| Dividend Date |
1,790,208,000 |
| Dividend Rate |
2.64 |
| Dividend Yield |
1.12 |
| Earnings Call Timestamp End |
1,786,048,200 |
| Earnings Call Timestamp Start |
1,786,048,200 |
| Earnings Growth |
0.024 |
| Earnings Quarterly Growth |
0.01 |
| Earnings Timestamp |
1,786,046,400 |
| Earnings Timestamp End |
1,793,304,000 |
| Earnings Timestamp Start |
1,793,304,000 |
| Ebitda |
2,095,774,976 |
| Ebitda Margins |
0.37071 |
| Enterprise To Ebitda |
16.235 |
| Enterprise To Revenue |
6.018 |
| Enterprise Value |
34,024,841,216 |
| Eps Current Year |
12.08573 |
| Eps Forward |
13.21748 |
| Eps Trailing Twelve Months |
10.62 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,787,184,000 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
210.2726 |
| Fifty Day Average Change |
30.057404 |
| Fifty Day Average Change Percent |
0.14294493 |
| Fifty Two Week Change Percent |
-13.000483 |
| Fifty Two Week High |
284.87 |
| Fifty Two Week High Change |
-44.539993 |
| Fifty Two Week High Change Percent |
-0.156352 |
| Fifty Two Week Low |
180.27 |
| Fifty Two Week Low Change |
60.059998 |
| Fifty Two Week Low Change Percent |
0.3331669 |
| Fifty Two Week Range |
180.27 - 284.87 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
802,099,800,000 |
| Five Year Avg Dividend Yield |
0.87 |
| Float Shares |
143,368,039 |
| Forward Eps |
13.21748 |
| Forward P E |
18.182741 |
| Free Cashflow |
939,248,256 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
11,370 |
| Fullday Change |
4.57001 |
| Fullday Change Percent |
1.93842 |
| Fullday Price |
240.33 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,785,542,400 |
| Gross Margins |
0.61618 |
| Gross Profits |
3,483,517,952 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0049900003 |
| Held Percent Institutions |
0.71529 |
| Implied Shares Outstanding |
144,252,306 |
| Industry |
Medical Instruments & Supplies |
| Industry Disp |
Medical Instruments & Supplies |
| Industry Key |
medical-instruments-supplies |
| Ir Website |
http://www.resmed.com/in/investors/investors.html?nc=investors |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,787,184,000 |
| Last Dividend Value |
0.66 |
| Last Fiscal Year End |
1,782,777,600 |
| Last Split Date |
1,283,212,800 |
| Last Split Factor |
2:1 |
| Long Business Summary |
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. |
| Long Name |
ResMed Inc. |
| Market |
us_market |
| Market Cap |
34,668,154,880 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_340196 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
1,523,293,056 |
| Next Fiscal Year End |
1,814,313,600 |
| Non Diluted Market Cap |
34,008,923,662 |
| Number Of Analyst Opinions |
16 |
| Open |
236.64 |
| Operating Cashflow |
1,805,828,992 |
| Operating Margins |
0.30857 |
| Overall Risk |
3 |
| Payout Ratio |
0.2301 |
| Peg Ratio |
1.37 |
| Phone |
858-836-5000 |
| Post Market Change |
0.0 |
| Post Market Change Percent |
0.0 |
| Post Market Price |
240.33 |
| Post Market Time |
1,787,959,804 |
| Previous Close |
235.76 |
| Price Eps Current Year |
19.885435 |
| Price Hint |
2 |
| Price To Book |
5.2639303 |
| Price To Sales Trailing12 Months |
6.13222 |
| Profit Margins |
0.26945 |
| Quick Ratio |
1.831 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.42105 |
| Region |
US |
| Regular Market Change |
4.57001 |
| Regular Market Change Percent |
1.93842 |
| Regular Market Day High |
241.025 |
| Regular Market Day Low |
235.515 |
| Regular Market Day Range |
235.515 - 241.025 |
| Regular Market Open |
236.64 |
| Regular Market Previous Close |
235.76 |
| Regular Market Price |
240.33 |
| Regular Market Time |
1,787,947,202 |
| Regular Market Volume |
1,386,747 |
| Return On Assets |
0.14002 |
| Return On Equity |
0.24269 |
| Revenue Growth |
0.086 |
| Revenue Per Share |
38.849 |
| Sand P52 Week Change |
0.20504117 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
3 |
| Shares Outstanding |
144,252,306 |
| Shares Percent Shares Out |
0.0887 |
| Shares Short |
12,794,915 |
| Shares Short Previous Month Date |
1,784,073,600 |
| Shares Short Prior Month |
13,541,103 |
| Short Name |
ResMed Inc. |
| Short Percent Of Float |
0.102299996 |
| Short Ratio |
9.21 |
| Source Interval |
15 |
| State |
CA |
| Symbol |
RMD |
| Target High Price |
320.0 |
| Target Low Price |
175.0 |
| Target Mean Price |
245.5 |
| Target Median Price |
235.0 |
| Total Cash |
1,469,234,048 |
| Total Cash Per Share |
10.185 |
| Total Debt |
825,918,976 |
| Total Revenue |
5,653,443,072 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
2.4 |
| Trailing Annual Dividend Yield |
0.010179845 |
| Trailing Eps |
10.62 |
| Trailing P E |
22.629944 |
| Trailing Peg Ratio |
1.3685 |
| Triggerable |
1 |
| Two Hundred Day Average |
228.87215 |
| Two Hundred Day Average Change |
11.457855 |
| Two Hundred Day Average Change Percent |
0.050062254 |
| Type Disp |
Equity |
| Volume |
1,386,747 |
| Website |
https://www.resmed.com |
| Zip |
92,123 |